The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
about
Locomotor effects of imidazoline I2-site-specific ligands and monoamine oxidase inhibitors in rats with a unilateral 6-hydroxydopamine lesion of the nigrostriatal pathwayPotentiation of Ligand Binding through Cooperative Effects in Monoamine Oxidase BImidazoline receptors and human brain disorders.High-throughput screening for genes that prevent excess DNA replication in human cells and for molecules that inhibit themInhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions.[3H]-RS-45041-190: a selective high-affinity radioligand for I2 imidazoline receptorsCharacterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine.Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites.Imidazoline binding sites on receptors and enzymes: emerging targets for novel antidepressant drugs?Allosteric modulation of semicarbazide-sensitive amine oxidase activities in vitro by imidazoline receptor ligands.Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors.Discriminative stimulus produced by the imidazoline I2 site ligand, 2 -BFI.Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons.Identification of imidazoline-receptor binding sites in cortex and medulla of the bovine adrenal gland. Colocalization with MAO-A and MAO-B.Pharmacologic and molecular discrimination of I2-imidazoline receptor subtypes.Identification of I1 and I2 imidazoline receptors in striatum membranes from different species.Methamphetamine reward in mice as assessed by conditioned place preference test with Supermex sensors: effect of subchronic clorgyline pretreatment.Body fat reduction without cardiovascular alteration in mice under oral treatment by the MAO inhibitor phenelzine.
P2860
Q24671046-1861B9A3-C9DA-4D3A-AC81-2AE7557C7028Q27664607-12361519-B015-416A-80C6-F8454FCD02EBQ33693078-08D00020-0672-4C85-8669-10D43CBBB3E6Q34111180-816C6002-EAF1-4E37-9166-DAFBE51AB784Q35026368-A3E68C7C-4797-4AD3-B3E6-21CD7DFB9209Q35161736-EE0ECE66-5CB2-4A17-914A-831C09067848Q35873028-47A64737-DC2F-4EAE-A7BF-48528059C665Q41835100-DAFF4836-380B-4DB9-BFB3-D349C01E09C1Q41861525-043EA31A-21F4-44A8-9376-1D3641667DDEQ43055558-3A3BFFD2-B526-4B58-BA4D-72ED1DDCCD5FQ43262083-572B5269-9BFF-48E4-9D4A-CF8EC2BC2ECFQ44372626-08D7B27B-8EEF-4B06-A981-E67A22F4946BQ45964812-0C2A277C-E27F-420B-9BDF-32224CB1BA7AQ47668415-74AE8714-322D-46DB-85EF-B1E15CC1B7E7Q48155205-9C71BFC2-4688-41B0-86EC-AE887DE54814Q48155212-8D64D4F7-E337-4759-8B6C-681AABAD7AB4Q48155223-3F473709-B0CC-413E-99BB-5D0C0BAB5090Q48442610-715DF32F-DC6F-4E09-8D68-0AEC156067FFQ51244360-A1CBABAE-09F6-44D7-B74B-EAAE15AF35A6
P2860
The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
The effects of phenelzine and ...... dazoline-preferring receptors.
@en
The effects of phenelzine and ...... dazoline-preferring receptors.
@nl
type
label
The effects of phenelzine and ...... dazoline-preferring receptors.
@en
The effects of phenelzine and ...... dazoline-preferring receptors.
@nl
prefLabel
The effects of phenelzine and ...... dazoline-preferring receptors.
@en
The effects of phenelzine and ...... dazoline-preferring receptors.
@nl
P2860
P1476
The effects of phenelzine and ...... idazoline-preferring receptors
@en
P2093
J A García-Sevilla
P2860
P304
P356
10.1111/J.1476-5381.1995.TB13280.X
P407
P50
P577
1995-02-01T00:00:00Z